Intravenous immunoglobulin in toxic epidermal necrolysis
- PMID: 16961531
- DOI: 10.1111/j.1365-4632.2006.02833.x
Intravenous immunoglobulin in toxic epidermal necrolysis
Comment on
-
Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.Int J Dermatol. 2004 Nov;43(11):847-51. doi: 10.1111/j.1365-4632.2004.02048.x. Int J Dermatol. 2004. PMID: 15533072 Review.
Similar articles
-
Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor.Indian Pediatr. 2004 Apr;41(4):392-5. Indian Pediatr. 2004. PMID: 15123870
-
[Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].Rev Med Chil. 2009 Mar;137(3):383-9. Epub 2009 Jun 15. Rev Med Chil. 2009. PMID: 19621180 Spanish.
-
Treatment of toxic epidermal necrolysis with intravenous immunoglobulin.J La State Med Soc. 2003 Sep-Oct;155(5):266-9. J La State Med Soc. 2003. PMID: 14748489
-
IVIG for the treatment of toxic epidermal necrolysis.Skin Therapy Lett. 2007 Feb;12(1):7-9. Skin Therapy Lett. 2007. PMID: 17361314 Review.
-
Toxic epidermal necrolysis and intravenous immunoglobulin: a review.Semin Cutan Med Surg. 2006 Jun;25(2):91-3. doi: 10.1016/j.sder.2006.04.004. Semin Cutan Med Surg. 2006. PMID: 16908399 Review.
Cited by
-
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.Drug Saf. 2013 Oct;36(10):953-80. doi: 10.1007/s40264-013-0084-0. Drug Saf. 2013. PMID: 23873481
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources